Inflation Reduction Act

HHS Considers Removing J&J’s Stelara from Medicare Drug Price Negotiations
HHS Considers Removing J&J’s Stelara from Medicare Drug Price Negotiations
BioSpace
JNJ
Stelara
HHS
Inflation Reduction Act
Medicare
drug pricing
Flag link:
HHS Challenges AstraZeneca’s Motion for Summary Judgement in IRA Lawsuit
HHS Challenges AstraZeneca’s Motion for Summary Judgement in IRA Lawsuit
BioSpace
AstraZeneca
legal
HHS
Inflation Reduction Act
Flag link:
'By hook or by crook': BIO CEO urges biotechs to be flexible on funding to survive tough times
'By hook or by crook': BIO CEO urges biotechs to be flexible on funding to survive tough times
Fierce Biotech
BIO
biotech
funding
Inflation Reduction Act
Flag link:
Relay Therapeutics Pauses Lirafugratinib Rare Cancer Plans Due to IRA
Relay Therapeutics Pauses Lirafugratinib Rare Cancer Plans Due to IRA
BioSpace
Relay Therapeutics
cancer
Inflation Reduction Act
Flag link:
Drugmakers face uphill battle in Medicare negotiation suits
Drugmakers face uphill battle in Medicare negotiation suits
Pharma Voice
Inflation Reduction Act
Medicare
drug pricing
Flag link:
US judge refuses to block Medicare from negotiating drug prices
US judge refuses to block Medicare from negotiating drug prices
Reuters
Medicare
legal
Inflation Reduction Act
drug pricing
Flag link:
Novo Nordisk challenges CMS drug price negotiations, then signs on to the program
Novo Nordisk challenges CMS drug price negotiations, then signs on to the program
Fierce Pharma
Novo Nordisk
CMS
drug pricing
Medicare
Inflation Reduction Act
Flag link:
Astellas Withdrew Its Inflation Reduction Act Lawsuit—Will Other Companies Follow?
Astellas Withdrew Its Inflation Reduction Act Lawsuit—Will Other Companies Follow?
BioSpace
Astellas
legal
Inflation Reduction Act
Flag link:
AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program
AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program
BioSpace
AstraZeneca
Bristol Myers Squibb
drug pricing
Inflation Reduction Act
Medicare
Flag link:
DOJ, Chamber of Commerce Tussle in Court Over IRA’s Drug Price Negotiations
DOJ, Chamber of Commerce Tussle in Court Over IRA’s Drug Price Negotiations
BioSpace
DOJ
Inflation Reduction Act
drug pricing
Medicare
legal
Flag link:
How Payers Are Reacting to Insulin Price Changes
How Payers Are Reacting to Insulin Price Changes
Drug Channels
payers
insurance
insulin
diabetes
drug pricing
Inflation Reduction Act
Medicare
Flag link:
HHS argues Merck 'lacks standing' to sue over Medicare price negotiations
HHS argues Merck 'lacks standing' to sue over Medicare price negotiations
Fierce Pharma
Merck
Inflation Reduction Act
HHS
legal
Flag link:
Is Medicare’s drug-price law affecting the way pharma brands advertise?
Is Medicare’s drug-price law affecting the way pharma brands advertise?
Medical Marketing and Media
DTC adveritising
drug pricing
Inflation Reduction Act
Flag link:
Astellas withdraws lawsuit challenging Medicare drug price negotiation plans
Astellas withdraws lawsuit challenging Medicare drug price negotiation plans
Reuters
Astellas
Medicare
prostate cancer
Xtandi
drug pricing
Inflation Reduction Act
Flag link:
Gilead-backed study warns IRA price negotiations could hit R&D harder than expected
Gilead-backed study warns IRA price negotiations could hit R&D harder than expected
Fierce Biotech
Gilead Sciences
Inflation Reduction Act
R&D
Flag link:
Novartis files suit against IRA after blockbuster Entresto makes CMS' price negotiations list
Novartis files suit against IRA after blockbuster Entresto makes CMS' price negotiations list
Fierce Pharma
Novartis
legal
Inflation Reduction Act
CMS
drug pricing
Entresto
Flag link:
AstraZeneca Latest to Sue Biden Administration Over IRA’s Drug Price Negotiations
AstraZeneca Latest to Sue Biden Administration Over IRA’s Drug Price Negotiations
BioSpace
AstraZeneca
legal
Joe Biden
drug pricing
Inflation Reduction Act
Flag link:
Boehringer Ingelheim Joins Legal Battle Against IRA Drug Pricing Provisions
Boehringer Ingelheim Joins Legal Battle Against IRA Drug Pricing Provisions
BioSpace
Boehringer Ingelheim
drug pricing
legal
Medicare
Inflation Reduction Act
Flag link:
Drug pricing concerns cross party lines to become 'core value' for voters, pollsters say
Drug pricing concerns cross party lines to become 'core value' for voters, pollsters say
Fierce Pharma
drug pricing
Inflation Reduction Act
Flag link:
Costliest Medicare drugs more than tripled in price since entering market: report
Costliest Medicare drugs more than tripled in price since entering market: report
Axios
drug pricing
Medicare Part D
Inflation Reduction Act
Flag link:

Pages